The best investment
LLS FUNDED RESEARCH
"Through our commitment to basic and translational research and the new generation of scientists, and our role as a catalyst for collaboration among biotechnology, government and clinical institutions, LLS is doing more than any cancer nonprofit to advance cutting-edge research and cures."
- Louis J. DeGennaro, Ph.D., LLS President and CEO
Hear from some of the world's most renowned blood cancer researchers about how LLS support helps makes it happen.
LLS CELEBRATES THE WORK OF DR. CARL JUNE - Fire with Fire
Dr. Carl June is the director of translational research at the Abramson Cancer Center at the University of Pennsylvania. He is best known for his research into T-cell therapies for treatment of cancer.